Patents by Inventor Robert Deans
Robert Deans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12511858Abstract: Methods and apparatus for automatically determining a diagnostic test result from a lateral flow assay are provided. The method comprises receiving at least one image of the lateral flow assay, identifying, with a hardware computer processor, a view window in the at least one image, determining, within the identified view window, a first signal strength for a control line and a second signal strength for one or more test lines, determining the diagnostic test result based on the first signal strength and/or the second signal strength, and outputting an indication of the diagnostic test result.Type: GrantFiled: August 31, 2022Date of Patent: December 30, 2025Inventors: Gabriel Davis, Jason R. Cox, Robert Deans, Joseph J. Walish
-
Patent number: 12385835Abstract: Compositions, articles, systems, and methods for sensing and/or authentication using luminescence imaging are generally provided. In some embodiments, an article (or packaging material of an article) is associated with an emissive material comprising an emissive species (e.g., a luminescent species). In some cases, the emissive species has an emission lifetime of at least 10 nanoseconds (ns). In some cases, a characteristic of an article (e.g., identity, authenticity, age, quality, purity) may be determined by obtaining an image (or series of images) comprising time-dependent information related to an emissive species. In certain instances, for example, the emission lifetime of an emissive species may be determined from an image (or series of images). Since the emission lifetime of an emissive species may be modified by a number of factors, including but not limited to binding or proximity to other molecules (e.g.Type: GrantFiled: June 22, 2023Date of Patent: August 12, 2025Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Patent number: 12320748Abstract: Compositions, articles, systems, and methods for sensing and/or authentication using luminescence imaging are generally provided. In some embodiments, an article (or packaging material of an article) is associated with an emissive material comprising an emissive species (e.g., a luminescent species). In some cases, the emissive species has an emission lifetime of at least 10 nanoseconds (ns). In some cases, a characteristic of an article (e.g., identity, authenticity, age, quality, purity) may be determined by obtaining an image (or series of images) comprising time-dependent information related to an emissive species. In certain instances, for example, the emission lifetime of an emissive species may be determined from an image (or series of images). Since the emission lifetime of an emissive species may be modified by a number of factors, including but not limited to binding or proximity to other molecules (e.g.Type: GrantFiled: June 22, 2023Date of Patent: June 3, 2025Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Publication number: 20250067670Abstract: Compositions, articles, systems, and methods for sensing and/or authentication using luminescence imaging are generally provided. In some embodiments, an article (or packaging material of an article) is associated with an emissive material comprising an emissive species (e.g., a luminescent species). In some cases, the emissive species has an emission lifetime of at least 10 nanoseconds (ns). In some cases, a characteristic of an article (e.g., identity, authenticity, age, quality, purity) may be determined by obtaining an image (or series of images) comprising time-dependent information related to an emissive species. In certain instances, for example, the emission lifetime of an emissive species may be determined from an image (or series of images). Since the emission lifetime of an emissive species may be modified by a number of factors, including but not limited to binding or proximity to other molecules (e.g.Type: ApplicationFiled: June 22, 2023Publication date: February 27, 2025Applicant: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Publication number: 20240181054Abstract: The application relates to biological components, methods, systems, and kits for modulating immune responses. The disclosed biological components include genetically modified cells comprising an inserted exogenous sequence in a major histocompatibility complex (MHC)-associated gene. The inserted exogenous sequence encodes a peptide and the genetically modified cells express a fusion protein comprising the peptide and at least a portion of the polypeptide encoded by the MHC-associated gene to form a modified MHC complex. The genetically modified cells may present the peptide as an antigen associated with the MHC complex and may be utilized in methods for modulating T cell activity, inducing an immune response, and inducing a tolerogenic response. As such, the disclosed biological components, methods, systems, and kits may be utilized in order to treat and/or prevent a disease or disorder in a subject in need thereof and to screen and validate clinically relevant antigens.Type: ApplicationFiled: March 14, 2022Publication date: June 6, 2024Inventors: Robert DEANS, Travis MAURES, Yueting ZHENG, Jared Carlson STEVERMER, Monique DAO, Phillip BALZANO, Rebecca NUGENT
-
Patent number: 11994518Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: GrantFiled: October 16, 2020Date of Patent: May 28, 2024Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Publication number: 20240077420Abstract: Compositions, articles, systems, and methods for sensing and/or authentication using luminescence imaging are generally provided. In some embodiments, an article (or packaging material of an article) is associated with an emissive material comprising an emissive species (e.g., a luminescent species). In some cases, the emissive species has an emission lifetime of at least 10 nanoseconds (ns). In some cases, a characteristic of an article (e.g., identity, authenticity, age, quality, purity) may be determined by obtaining an image (or series of images) comprising time-dependent information related to an emissive species. In certain instances, for example, the emission lifetime of an emissive species may be determined from an image (or series of images). Since the emission lifetime of an emissive species may be modified by a number of factors, including but not limited to binding or proximity to other molecules (e.g.Type: ApplicationFiled: June 22, 2023Publication date: March 7, 2024Applicant: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Patent number: 11796539Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: GrantFiled: October 16, 2020Date of Patent: October 24, 2023Assignee: C2Sense, Inc.Inventors: Timothy Manning, Jason R. Cox, Robert Deans, Zhengguo Zhu, Brian E. Fratto, Gabriel Davis
-
Patent number: 11726037Abstract: Compositions, articles, systems, and methods for sensing and/or authentication using luminescence imaging are generally provided. In some embodiments, an article (or packaging material of an article) is associated with an emissive material comprising an emissive species (e.g., a luminescent species). In some cases, the emissive species has an emission lifetime of at least 10 nanoseconds (ns). In some cases, a characteristic of an article (e.g., identity, authenticity, age, quality, purity) may be determined by obtaining an image (or series of images) comprising time-dependent information related to an emissive species. In certain instances, for example, the emission lifetime of an emissive species may be determined from an image (or series of images). Since the emission lifetime of an emissive species may be modified by a number of factors, including but not limited to binding or proximity to other molecules (e.g.Type: GrantFiled: October 16, 2020Date of Patent: August 15, 2023Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Patent number: 11726093Abstract: Components, systems, and methods for gas sensing identification are generally disclosed. In some embodiments, a characteristic of an article (e.g., identity, authenticity, property, product associated information such as age or quality, etc.) may be determined by determining the presence (e.g., an amount) or absence of a chemical compound (or compounds) emanating from the article. For example, the presence or absence of the compound (or compounds) emanating from the article identifies a characteristic of the article. In some embodiments, the chemical compound(s) has been proactively added to the article. That is to say, in some embodiments, the chemical compound is not inherently associated with the article but is added in order to, for example, identify a characteristic of the article.Type: GrantFiled: January 31, 2020Date of Patent: August 15, 2023Assignee: C2Sense, Inc.Inventors: Robert Deans, John Benjamin Goods, Alexander Robertson Petty, Jan Markus Schnorr, Timothy Manning Swager, Travis Matthew Theis, Laura Jane Tschiegg, Joseph J. Walish, Nicole Katheryn Keller
-
Patent number: 11662346Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: GrantFiled: October 16, 2020Date of Patent: May 30, 2023Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Patent number: 11656226Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: GrantFiled: October 16, 2020Date of Patent: May 23, 2023Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans, Zhengguo Zhu, Brian E. Fratto, Gabriel Davis
-
Patent number: 11513118Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: GrantFiled: October 16, 2020Date of Patent: November 29, 2022Assignee: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans
-
Patent number: 11197889Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.Type: GrantFiled: November 6, 2017Date of Patent: December 14, 2021Assignees: ABT Holding Company, Oregon Health & Science UniversityInventors: Richard Maziarz, Magdalena Kovacsovics, Philip Streeter, Robert Deans, Wouter Van't Hof
-
Publication number: 20210346429Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.Type: ApplicationFiled: July 12, 2021Publication date: November 11, 2021Applicants: ABT Holding Company, Oregon Health & Science UniversityInventors: Richard MAZIARZ, Magdalena KOVACSOVICS, Philip STREETER, Robert DEANS, Wouter VAN'T HOF
-
Publication number: 20210228626Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.Type: ApplicationFiled: April 9, 2021Publication date: July 29, 2021Applicants: ABT Holding Company, OREGON HEALTH & SCIENCE UNIVERISTYInventors: Robert DEANS, Richard MAZIARZ, Magdalena KOVACSOVICS, Philip STREETER, Wouter VAN'T HOF
-
Publication number: 20210205359Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.Type: ApplicationFiled: January 12, 2021Publication date: July 8, 2021Applicants: ABT Holding Company, OREGON HEALTH & SCIENCE UNIVERISTYInventors: Robert Deans, Richard Maziarz, Magdalena Kovacsovics, Philip Streeter, Wouter Van't Hof
-
Patent number: 11000546Abstract: Isolated cells are described that are not embryonic stem cells, not embryonic germ cells, and not germ cells. The cells can differentiate into at least one cell type of each of at least two of the endodermal, ectodermal, and mesodermal lineages. The cells do not provoke a harmful immune response. The cells can modulate immune responses. As an example, the cells can suppress an immune response in a host engendered by allogeneic cells, tissues, and organs. Methods are described for using the cells, by themselves or adjunctively, to treat subjects. For instance, the cells can be used adjunctively for immunosuppression in transplant therapy. Methods for obtaining the cells and compositions for using them also are described.Type: GrantFiled: May 3, 2018Date of Patent: May 11, 2021Assignees: ATHERSYS, INC., OREGON HEALTH & SCIENCE UNIVERISTYInventors: Robert Deans, Richard Maziarz, Magdalena Kovacsovics, Philip Streeter, Wouter Van't Hof
-
Publication number: 20210123921Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: ApplicationFiled: October 16, 2020Publication date: April 29, 2021Applicant: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans, Jeffrey N. Takle, Gabriel Davis, Andrew Wheeler, Steven R. Fletcher, Andrew P. Nelson
-
Publication number: 20210116384Abstract: Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.Type: ApplicationFiled: October 16, 2020Publication date: April 22, 2021Applicant: C2Sense, Inc.Inventors: Timothy Manning Swager, Jason R. Cox, Robert Deans